Reactions with Antisera and Pathological Effects of Staphylococcus aureus Gamma-Toxin in the Cornea

References

• Spaulding AR, Lin YC, Merriman JA, Brosnahan AJ, Peterson ML, Schlievert PM. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine 2012;30:5099–5109.
   PubMed Web of Science ®Google Scholar
• Camargo IL, Gilmore MS. Staphylococcus aureus-probing for host weakness? J Bacteriol 2008;190:2253–2256.
   PubMed Web of Science ®Google Scholar
• McNamara PJ, Bayer AS. A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endophthalmitis. Infect Immun 2005;73:3806–3809.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001;32:S114–S132.
   PubMed Web of Science ®Google Scholar
• Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective endocarditis in the U.S., 1998–2009: a nationwide study. PLoS One 2013;8:e60033.
   Google Scholar
• Wright JA, Nair SP. Interaction of staphylococci with bone. Int J Med Microbiol 2010;300:193–204.
   PubMed Web of Science ®Google Scholar
• Grumann D, Nubel U, Broker BM. Staphylococcus aureus toxins – Their functions and genetics. Infect Genet Evol 2014;21:583–592.
   PubMed Web of Science ®Google Scholar
• Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun1993;61:3879–3885.
   PubMed Web of Science ®Google Scholar
• Archer GL. Staphylococcus aureus: A well-armed pathogen. Clin Infect Dis 1998;26:1179–1181.
   PubMed Web of Science ®Google Scholar
• Surewaard BGJ, de Haas CJC, Vervoot F, et al. Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol 2013;15:1427–1437.
   PubMed Web of Science ®Google Scholar
• Fraser JD, Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008;225:226–243.
   PubMed Web of Science ®Google Scholar
• Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998;6:484–488.
   PubMed Web of Science ®Google Scholar
• Jeng BH, Gritz DC, Kumar AB, et al. Epidemiology of ulcerative keratitis in northern California. Arch Ophthalmol 2010;128:1022–1028.
   PubMed Web of Science ®Google Scholar
• Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003;48:403–423.
   PubMed Web of Science ®Google Scholar
• Lemp MA, Nichols KK. Blepharitis in the United States 2009: A survey-based perspective on prevalence and treatment. Ocul Surf 2009;7:S1–S14.
   PubMed Web of Science ®Google Scholar
• Willcox MDP. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom 2011;94:161–168.
   PubMed Web of Science ®Google Scholar
• Cavuoto K, Zutshi D, Karp CL, Miller D, Feuer W. Update on bacterial conjunctivitis in south Florida. Ophthalmology 2008;115:51–56.
   PubMed Web of Science ®Google Scholar
• Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol 1984;68:524–528.
   PubMed Web of Science ®Google Scholar
• Schimel AM, Miller D, Flynn HW Jr. Endophthalmitis isolates and antibiotic susceptibilities: A 10-year review of culture-proven cases. Am J Ophthalmol 2013;156:50–52.
   PubMed Web of Science ®Google Scholar
• Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000;107:1497–1502.
   PubMed Web of Science ®Google Scholar
• Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 2004;137:725–731.
   PubMed Web of Science ®Google Scholar
• Kaye R, Kaye A, Sueke H, et al. Recurrent bacterial keratitis. Invest Ophthalmol Vis Sci 2013;54:4136–4139.
   PubMed Web of Science ®Google Scholar
• O’Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun 1997;65:1571–1578.
   PubMed Web of Science ®Google Scholar
• Dajcs JJ, Thibodeaux B, Girgis D, O’Callaghan RJ. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. DNA Cell Bio 2002;21:375–382.
   PubMed Web of Science ®Google Scholar
• Dajcs JJ, Austin MS, Sloop GD, et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci 2002;43:1109–1115.
   PubMed Web of Science ®Google Scholar
• Callegan MC, Engelbert M, Parke II DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev 2002;15:111–124.
   PubMed Web of Science ®Google Scholar
• Callegan MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun 2009;67:3348–3356.
   Google Scholar
• Supersac G, Piemont Y, Kubina M, Prevost G, Foster TJ. Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphyloccocus aureus. Microb Pathog 1998;24:241–251.
   PubMed Web of Science ®Google Scholar
• Booth MC, Atkuri RV, Nanda SK, Iandolo JJ, Gilmore MS. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci 1995;36:1828–1836.
   PubMed Web of Science ®Google Scholar
• Booth MC, Cheung AL, Hatter KL, Jett BD, Callegan MC, Gilmore MS. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun 1997;65:1550–1556.
   PubMed Web of Science ®Google Scholar
• Girgis D, Sloop GD, Reed J, O’Callaghan RJ. Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci 2005;46:2064–2070.
   PubMed Web of Science ®Google Scholar
• Laventie BJ, Rademaker HJ, Saleh M, et al. Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins. Proc Natl Acad Sci USA 2001;108:16404–16409.
   Web of Science ®Google Scholar
• Siqueira JA, Speeg-Schatz C, Freitas FIS, Sahel J, Monteil H, Prevost G. Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J Med Microbiol 1997;46:486–494.
   PubMed Web of Science ®Google Scholar
• Finck-Barbancon V, Prevost G, Piemont Y. Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol 1991;142:75–85.
   PubMed Web of Science ®Google Scholar
• Iacovache I, van der Goot FG, Pernot L. Pore formation: an ancient yet complex form of attack. Biochim Biophys Acta 2008;1778:1611–1623.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Kawai Y, Tanaka Y, et al. Crystal structure of the octameric pore of staphylococcal gamma-hemolysin reveals the beta-barrel pore formation mechanism by two components. Proc Natl Acad Sci USA 2011;108:17314–17319.
   PubMed Web of Science ®Google Scholar
• Miles G, Movileanu L, Bayley H. Subunit composition of a bicomponent toxin: Staphylococcal leukotoxin forms an octameric transmembrane pore. Protein Sci 2002;11:894–902.
   PubMed Web of Science ®Google Scholar
• Joubert O, Viero G, Keller D, et al. Engineered covalent leucotoxins heterodimers form functional pores: insights into S-F interactions. Biochem J 2006;396:381–389.
   PubMed Web of Science ®Google Scholar
• Gravet A, Colin DA, Keller D, Giradot R, Monteil H, Prevost G. Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett 1998;436:202–208.
   PubMed Web of Science ®Google Scholar
• Nilsson I, Hartford O, Foster TJ, Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 1999;67:1045–1049.
   PubMed Web of Science ®Google Scholar
• Plommet M. Preparation and purification of gamma-hemolysin of staphylococci. Methods Enzymol 1988;165:8–16.
   PubMed Web of Science ®Google Scholar
• O’Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci 1996;37:534–543.
   PubMed Web of Science ®Google Scholar
• Moreau JM, Sloop GD, Engel LS, Hill JM, O’Callaghan RJ. Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. Curr Eye Res 1997;16:1221–1228.
   PubMed Web of Science ®Google Scholar
• O’Callaghan RJ. Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998. Cornea 1999;18:532–537.
   Google Scholar
• Hume E, Dajcs J, Moreau J, Cannon B, O’Callaghan RJ. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect Immun 2000;68:6052–6055.
   PubMed Web of Science ®Google Scholar
• Caballero A, Foletti D, Bierdeman M, et al. Effectiveness of alpha-toxin Fab monoclonal antibody therapy in limiting the pathology of Staphylococcus aureus keratitis. Ocul Immunol Inflamm 2015;23:297–303.
   PubMed Web of Science ®Google Scholar
• Zaidi T, Zaidi T, Yoong P, Pier GB. Staphylococcus aureus corneal infections: Effect of the Panton-Valentine Leukocidin (PVL) and antibody to PVL on virulence and pathology. Invest Ophthalmol Vis Sci 2013;54:4430–4438.
   PubMed Web of Science ®Google Scholar